Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan

被引：13

作者：

Arashiro, Takeshi ^{[1
,2
,3
,4
]}

Arima, Yuzo ^{[1
]}

Kuramochi, Jin ^{[5
,6
]}

Muraoka, Hirokazu ^{[7
]}

Sato, Akihiro ^{[8
]}

Chubachi, Kumi ^{[9
]}

Yanai, Atsushi ^{[10
]}

Arioka, Hiroko ^{[10
]}

Uehara, Yuki ^{[11
,12
]}

Ihara, Genei ^{[13
]}

Kato, Yasuyuki ^{[14
]}

Yanagisawa, Naoki ^{[15
]}

Ueda, Akihiro ^{[16
]}

Kato, Hideaki ^{[17
]}

Oka, Hideaki ^{[18
]}

Nishida, Yusuke ^{[18
]}

Nidaira, Yuki ^{[5
]}

Asami, Takahiro ^{[19
]}

Jinta, Torahiko ^{[20
]}

Nakamura, Akira ^{[21
]}

Oba, Kunihiro ^{[22
]}

Taniyama, Daisuke ^{[23
]}

Yamamoto, Kei ^{[18
]}

Tanaka, Katsushi ^{[17
]}

Ueshima, Kankuro ^{[24
]}

Fuwa, Tetsuji ^{[24
]}

Stucky, Ashley ^{[1
]}

Suzuki, Tadaki ^{[2
]}

Smith, Chris ^{[3
]}

Hibberd, Martin ^{[3
]}

Ariyoshi, Koya ^{[4
]}

Suzuki, Motoi ^{[1
]}

机构：

[1] Natl Inst Infect Dis, Ctr Surveillance Immunizat & Epidemiol Res, Tokyo, Japan

[2] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan

[3] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England

[4] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan

[5] Kuramochi Clin Interpk, Tochigi, Japan

[6] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Tokyo, Japan

[7] Clin TAMACHI, Tokyo, Japan

[8] KARADA Internal Med Clin, Tokyo, Japan

[9] Chubachi Internal Resp Med Clin, Tokyo, Japan

[10] St Lukes Int Hosp, Dept Gen Internal Med, Tokyo, Japan

[11] St Lukes Int Hosp, Dept Clin Lab, Tokyo, Japan

[12] Fujita Hlth Univ, Sch Med, Dept Infect Dis, Aichi, Japan

[13] Machida Ekimae Naika Clin, Tokyo, Japan

[14] Int Univ Hlth, Welf Narita Hosp, Dept Infect Dis, Chiba, Japan

[15] Yanagisawa Clin, Tokyo, Japan

[16] Japanese Red Cross Med Ctr, Dept Infect Dis, Tokyo, Japan

[17] Yokohama City Univ Med, Infect Prevent & Control Dept, Yokohama, Japan

[18] Saitama Med Ctr, Dept Gen Internal Med & Infect Dis, Saitama, Japan

[19] Sano Kosei Gen Hosp, Dept Internal Med, Tochigi, Japan

[20] St Lukes Int Hosp, Dept Pulm Med, Tokyo, Japan

[21] Asahi Gen Hosp, Dept Internal Med, Chiba, Japan

[22] Showa Gen Hosp, Dept Pediat, Tokyo, Japan

[23] Showa Gen Hosp, Dept Infect Dis, Tokyo, Japan

[24] NATURALI Co Ltd, Tokyo, Japan

来源：

OPEN FORUM INFECTIOUS DISEASES | 2023年 / 10卷 / 06期

关键词：

COVID-19; SARS-CoV-2; variants; test-negative design; vaccine effectiveness;

D O I：

10.1093/ofid/ofad240

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In this multicenter, prospective, test-negative, case-control study in Japan, the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent coronavirus disease 2019 mRNA vaccines against symptomatic infection during the BA.5-dominant period was high compared with no vaccination (65% and 76%) and moderate compared with monovalent vaccines administered over half a year earlier (46% combined). In this multi-center study in Japan, the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent vaccines against symptomatic infection during the BA.5-dominant period was high compared to no vaccination (65%/76%) and moderate compared to monovalent vaccines >6 months before (46% combined).

引用

页数：6

共 50 条

[41] Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients [J].

Fernandez-Ruiz, Mario ;

Almendro-Vazquez, Patricia ;

Redondo, Natalia ;

Ruiz-Merlo, Tamara ;

Abella, Sandra ;

Somoza, Adan ;

Lopez-Medrano, Francisco ;

Juan, Rafael San ;

Loinaz, Carmelo ;

Andres, Amado ;

Paz-Artal, Estela ;

Aguado, Jose Maria .

TRANSPLANTATION DIRECT, 2023, 9 (10) :E1536

[42] SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity [J].

Richardson, Simone I. ;

Mzindle, Nonkululeko ;

Motlou, Thopisang ;

Manamela, Nelia P. ;

van der Mescht, Mieke A. ;

Lambson, Bronwen E. ;

Everatt, Josie ;

Amoako, Daniel Gyamfi ;

Balla, Sashkia ;

von Gottberg, Anne ;

Wolter, Nicole ;

de Beer, Zelda ;

de Villiers, Talita Roma ;

Bodenstein, Annie ;

van den Berg, Gretha ;

Abdullah, Fareed ;

Rossouw, Theresa M. ;

Boswell, Michael T. ;

Ueckermann, Veronica ;

Bhiman, Jinal N. ;

Moore, Penny L. .

JOURNAL OF VIROLOGY, 2024, 98 (07)

[43] COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study) [J].

Arashiro, Takeshi ;

Arima, Yuzo ;

Muraoka, Hirokazu ;

Sato, Akihiro ;

Oba, Kunihiro ;

Uehara, Yuki ;

Arioka, Hiroko ;

Yanai, Hideki ;

Kuramochi, Jin ;

Ihara, Genei ;

Chubachi, Kumi ;

Yanagisawa, Naoki ;

Nagura, Yoshito ;

Kato, Yasuyuki ;

Ueda, Akihiro ;

Numata, Akira ;

Kato, Hideaki ;

Ishii, Koji ;

Ooki, Takao ;

Oka, Hideaki ;

Nishida, Yusuke ;

Stucky, Ashley ;

Smith, Chris ;

Hibberd, Martin ;

Ariyoshi, Koya ;

Suzuki, Motoi .

CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) :E108-E115

[44] Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants [J].

Pokorska-Spiewak, Maria ;

Pawlowska, Malgorzata ;

Ciechanowski, Przemyslaw ;

Peregrym, Michal ;

Dobrzeniecka, Anna ;

Sobolewska-Pilarczyk, Malgorzata ;

Franczak, Justyna ;

Majda-Stanislawska, Ewa ;

Szczepanska, Barbara ;

Zaleska, Izabela ;

Flisiak, Robert .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (02) :149-154

[45] Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5, and XBB transmission [J].

Wee, Liang En ;

Tay, An Ting ;

Chiew, Calvin ;

Young, Barnaby Edward ;

Wong, Betty ;

Lim, Ruth ;

Li Lee, Ching ;

Tan, Joyce ;

Vasoo, Shawn ;

Lye, David Chien ;

Tan, Kelvin Bryan .

CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (10) :1328-1333

[46] Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France [J].

Auvigne, Vincent ;

Tchuem, Cynthia Raissa Tamandjou ;

Schaeffer, Justine ;

Vaux, Sophie ;

Du Chatelet, Isabelle Parent .

VACCINE, 2023, 41 (38) :5490-5493

[47] Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV [J].

Augello, Matteo ;

Bono, Valeria ;

Rovito, Roberta ;

Tavelli, Alessandro ;

Santoro, Andrea ;

Tincati, Camilla ;

Vergori, Alessandra ;

Azzini, Anna Maria ;

Righi, Elda ;

Spiteri, Gianluca ;

Porru, Stefano ;

Meschi, Silvia ;

Notari, Stefania ;

Maggi, Fabrizio ;

Antinori, Andrea ;

Tacconelli, Evelina ;

d'Arminio Monforte, Antonella ;

Marchetti, Giulia .

COMMUNICATIONS MEDICINE, 2025, 5 (01)

[48] SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period [J].

Filippatos, Filippos ;

Tatsi, Elizabeth-Barbara ;

Dourdouna, Maria-Myrto ;

Zoumakis, Emmanouil ;

Margeli, Alexandra ;

Syriopoulou, Vasiliki ;

Michos, Athanasios .

DIAGNOSTICS, 2024, 14 (10)

[49] Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study [J].

Gram, Mie Agermose ;

Thiesson, Emilia Myrup ;

Pihlstrom, Nicklas ;

Perala, Jori ;

Poukka, Eero ;

Leino, Tuija ;

Ljung, Rickard ;

Andersson, Niklas Worm ;

Hviid, Anders .

JOURNAL OF INFECTION, 2024, 89 (04)

[50] Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2 [J].

Underwood, Alexander P. ;

Solund, Christina ;

Jacobsen, Kivin ;

Binderup, Alekxander ;

Fernandez-Antunez, Carlota ;

Mikkelsen, Lotte S. ;

Inekci, Dilek ;

Villadsen, Signe Lysemose ;

Castruita, Jose A. S. ;

Pinholt, Mette ;

Fahnoe, Ulrik ;

Ramirez, Santseharay ;

Brix, Liselotte ;

Weis, Nina ;

Bukh, Jens .

FRONTIERS IN IMMUNOLOGY, 2024, 15

← 1 2 3 4 5 →